Rac GTPases in Hematological Malignancies

V Durand-Onayli; T Haslauer; A Harzschel; Tanja Hartmann

doi:10.3390/ijms19124041

Rac GTPases in Hematological Malignancies

V Durand-Onayli, T Haslauer (Co-author), A Harzschel, Tanja Hartmann^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Review article › peer-review

17 Citations (Web of Science)

Original language	English
Pages (from-to)	4041
Journal	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume	19
Issue number	12
DOIs	https://doi.org/10.3390/ijms19124041
Publication status	Published - 2018

Keywords

CHRONIC LYMPHOCYTIC-LEUKEMIA
SMALL-MOLECULE INHIBITOR
NUCLEOTIDE EXCHANGE FACTOR
HEMATOPOIETIC STEM-CELLS
RHO-GTPASES
LYMPHOBLASTIC-LEUKEMIA
PROGNOSTIC RELEVANCE
THERAPEUTIC TARGET
TYROSINE KINASE
CDC42 GTPASES

Access to Document

10.3390/ijms19124041

Cite this

@article{739cc56e917449ec8f3784e82467ad56,

title = "Rac GTPases in Hematological Malignancies",

keywords = "CHRONIC LYMPHOCYTIC-LEUKEMIA, SMALL-MOLECULE INHIBITOR, NUCLEOTIDE EXCHANGE FACTOR, HEMATOPOIETIC STEM-CELLS, RHO-GTPASES, LYMPHOBLASTIC-LEUKEMIA, PROGNOSTIC RELEVANCE, THERAPEUTIC TARGET, TYROSINE KINASE, CDC42 GTPASES",

author = "V Durand-Onayli and T Haslauer and A Harzschel and Tanja Hartmann",

note = "Durand-Onayli, V; Haslauer, T; Haerzschel, A; Hartmann, TN: Paracelsus Med Univ, Dept Internal Med Hematol Med Oncol Hemostaseol I, Canc Cluster Salzburg, Ctr Oncol,SCRI,LIMCR, A-5020 Salzburg, Austria; ",

year = "2018",

doi = "10.3390/ijms19124041",

language = "English",

volume = "19",

pages = "4041",

journal = "INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES",

issn = "1422-0067",

publisher = "MDPI",

number = "12",

}

TY - JOUR

T1 - Rac GTPases in Hematological Malignancies

AU - Durand-Onayli, V

AU - Haslauer, T

AU - Harzschel, A

AU - Hartmann, Tanja

N1 - Durand-Onayli, V; Haslauer, T; Haerzschel, A; Hartmann, TN: Paracelsus Med Univ, Dept Internal Med Hematol Med Oncol Hemostaseol I, Canc Cluster Salzburg, Ctr Oncol,SCRI,LIMCR, A-5020 Salzburg, Austria;

PY - 2018

Y1 - 2018

KW - CHRONIC LYMPHOCYTIC-LEUKEMIA

KW - SMALL-MOLECULE INHIBITOR

KW - NUCLEOTIDE EXCHANGE FACTOR

KW - HEMATOPOIETIC STEM-CELLS

KW - RHO-GTPASES

KW - LYMPHOBLASTIC-LEUKEMIA

KW - PROGNOSTIC RELEVANCE

KW - THERAPEUTIC TARGET

KW - TYROSINE KINASE

KW - CDC42 GTPASES

U2 - 10.3390/ijms19124041

DO - 10.3390/ijms19124041

M3 - Review article

C2 - 30558116

SN - 1422-0067

VL - 19

SP - 4041

JO - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

JF - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IS - 12

ER -